Introduction
About 36.7 million people worldwide have been infected with HIV. [1] Total nu mber of people liv ing with HIV (PLHIV) in India is 21.17 lakhs and the adult prevalence is estimated to be 0.26% (0.30% among male and 0.22% among female). Manipur state has the highest adult prevalence of HIV/AIDS (1.15%) in India . [2] Renal d isease is a relatively common co mplication in HIV patients and prevalence is about 5-30%. [3, 4] Several studies about the renal profile of HIV/AIDS patients have been done in other parts of India but data from the north east India is lacking. [5, 6, 7, 8] Spectrum o f renal diseases in patients with HIV/AIDS is wide and can range fro m simply acid base disturbances to AKI and several glo merular lesions such as IgA nephropathy, memb ranous -nephropathy, memb ranoproliferative, mesangial proliferative, diffuse proliferative, or crescentic glo meru lonephritis. [9, 10, 11] HIV-associated nephropathy (HIVAN) is characteristic chronic kidney diseases developing in 5-10% HIV infected cases, and is caused by direct cytopathic effects of HIV on kidney cells and chronic inflammat ion med iated by cytokines. HIV viral load and the immune status of HIV positive patient is reflected best by absolute CD4 cell count. Apart fro m d irect effects of HIV v irus, other factors contributing to renal dysfunction includes drug-induced renal toxicity, opportunistic infections, hepatitis C infection and traditional factors like hypertension, diabetes. Adoption of tenofovir in first-line ART reg imens by WHO may pose a risk for continuous rise of renal dysfunction in HIV-positive patients. [5, 12, 13, 14] Several studies have shown that ART prevents renal dysfunction in HIV patients but still an ongoing loss of creatinine clearance has been observed even with HIV viral suppression, which may be caused by intermittent viremia and other secondary factors in HIV positive patients. [15] We conducted a cross sectional study to establish the prevalence of renal dysfunction in ART naïve HIV positive patients and correlate this to the CD4 cell counts. Patients of age more than 15 years who were tested HIVantibody positive (as per NACO guidelines) and had never taken ART were included in the study. Those HIV positive patients who were below 15 years of age; had pre-existing renal parenchymal disease due to diabetes, long standing hypertension, cardiac failure, chronic liver d isease and collagen vascular disease and those who are taking currently or had taken ART drugs in the past, were excluded fro m the study.
Aims and Objects
Patients with serum creatinine ≥ 1.5 mg/dl and/or spot proteinuria ≥1+ or 24-h urinary protein ≥500 mg were classified as having renal involvement. 24 hour urinary protein estimat ion was done in patients with spot proteinuria ≥1+.
Written informed consent was obtained from all the cases before including them in the study. Detailed clinical, personal and family history was collected from the patients by means of oral questionnaire. Routine examination of blood, urine and CD4 counts were done as per NACO Descriptive and inferential statistical analysis has been carried out in the present study. Results on continuous measurements are presented on Mean ± SD (Min -Max) and results on categorical measurements are presented in number (%). Significance is assessed at 5 % level of significance. Chi-square and Fisher Exact test has been used to find the significance of study parameters on categorical scale between two or more groups as and when appropriate. All pvalues were two-sided. Pearson's coefficient(r) was used to see the correlation. P value < 0.05 was significant.
The Statistical software namely SPSS 21 and R environment ver.3.2.2 were used for the analysis of the data.
Informed Consent
Informed written consent was taken fro m all the participants. Privacy and confidentiality was strictly maintained in all the cases by coding the patients .
Ethics Approval
Ethical approval was obtained from the Research Ethics Board, RIMS, Imphal before beginning of the study.
Results and Observation
The present study included 295 HIV positive patients. Maximu m nu mber of patients were in age group 31-40 years (113 cases, 37.31%). The mean age was 36.3 years (range 18 -67 years). Most of the patients belonged to reproductive age group. 200 (67.79%) were male and 105 (35.59%) were females, of wh ich 17 were p regnant.
Out of 295 cases, 52 (17.62%) had proteinuria on urine examination. The mean 24-h urinary protein in proteinuria cases was 897.05 ± 402.03 mg/day. 43 (82.7%) cases had 24 h urine protein between 500-1000 mg/day, while proteinuria of >1g/day was found in 9 (17.3%) cases. Negative correlation was found between albuminuria and CD4 cell count (r = -0.489, p value=0.000). 
Discussion
In our study 52/293 (17.74%) patients had proteinuria on urinalysis. This is consistent with the study done by Varma PP et al [6] who reported 25/142 (17.6%)to have proteinuria. Similarly, Gupta V et al [5] reported that 58/392 (14.79%) in ART naïve cases to have proteinuria. While Janakiraman H et al [9] reported 29/104 (27%) cases and Prakash J et al [3] reported 112/ 293 (38.2%) cases to have proteinuria. The discrepancy in the later two studies was probably due to inclusion of HIV patients already on ART and also due to difference in sample size. The mean 24 hour urinary protein in the cases with spot proteinuria in our study was 897.05±402.03 mg/day. However, the study of Gupta V et al [5] showed that mean 24 hour urinary protein in cases with spot proteinuria was 1561±906 mg/day. The difference with the presence study might be due to inclusion of patients on ART in his study. No patient in present study had nephrotic range proteinuria. Proteinuria >1g/day was found in 9(17.3%) cases in the present study, which was similar to Prakash J et al [3] who found 16/112 (14.2%) patients to have proteinuria >1g/day.
Among cases of renal dysfunction whose creatinine clearance ≤ 60ml/ min/1.73m 2 , mean seru m creat inine in the present study was 2.87 ± 3.01 mg/dl. The study done by Gupta V et al [5] showed a higher mean seru m creat inine of 4.60±3.17 mg/dl.
Our study depicted a negative correlation between CD4 count and albuminuria, which was statistically significant and was in agreement with study results of Janakiraman H et al [9] .
Present study showed a positive correlation between CD4 counts and creatinine clearance in the study population. Out of 106 cases with CD4 counts ≤200 cells/µL, 25 (23.58%) cases had renal dysfunction. In the study done by Mulenga LB et al [13] , renal dysfunction was assessed by CockcroftGault formu la and 33.5% patients had renal insufficiency. When Patients with CD4+ cell counts ≥200 cells/µL were more likely to have reduced creatinine clearance compared to those with CD4+ counts between 50 -199 cells/ µL (ARR = 1.2, 95% CI: 1.1-1.2) and those with CD4+ counts less than 50 cells/µL (ARR = 1.4, 95% CI: 1.4-1.5). Similar results were reported by Atta MG et al [17] , that HIV associated nephropathy cases had a significantly higher creatinine (8.2mg% versus 2.5mg%) and a lower CD4 cell counts (158/µL versus 349/ µL; p < 0.01). There study also depicted that IVDU, HCV and hypertension were not associated with HIVAN.
Rossi C et al [14] reported that higher CKD incidence rate among HCV co-infected than HIV mono-in fected patients (26.0 per 1000 PYFU vs. 10.7 per 1000 PYFU) which was contrary to the findings of present study and the study done by Atta MG et al [17] . Even with high prevalence of HCV infection in Manipur, present study didn't show significant association between HCV infect ion and renal dysfunction in HIV patients. The reason might be that previous study was a cohort study while later t wo are cross sectional studies, which might not assess the impact of HCV on renal dysfunction. However the domain of renal dysfunction in HIV-HCV co-infection needs an elaborative study in present study set up due to high prevalence of HCV infection in Manipur.
Future Scope
HIV infection appears to be a risk factor for developing chronic kidney disease. Even in patients with normal seru m creatinine, the presence of proteinuria may be an early indicator of chronic kidney disease. If initial urine analysis results are normal, annual follow-up urine analysis are recommended to screen for newly developed kidney damage for high risk groups-diabetes, hypertension, hepatitis C virus co-infection, high HIV-RNA levels or CD4 counts <200 cells/µL. Main limitations of the study were that firstly HIV viral load was not performed in the cases and renal biopsy was not done in the cases with proteinuria. The domain o f renal dysfunction in HIV-HCV co-infection needs an elaborative study including HCV v iral load and genotyping to give better insight. However, HCV v iral load was not done due to limitation of study set up and financial constraints. Finally a larger samp le size with follow up study is needed for more robust results.
Conclusion
Present study was conducted in the Manipur state of Northeastern India, having highest prevalence of HIV/AIDS and a high prevalence of HCV infection in India. The study included ART naïve patients with HIV/AIDS and depicted that renal dysfunction is quite prevalent in the study population. Renal dysfunction was more common in the patients having lower CD4 counts. Study showed a significant negative correlation between CD4 counts an d albuminuria. It is recommended to use proteinuria as a routine screening tool in high risk HIV cases, especially HIV-HCV co-infection and HIV with low CD4 counts, for early detection and management of renal dysfunction. Such patients might require more frequent follow up than recommended by NACO guidelines. Ho wever a larger prospective study with a larger sample size is needed to formulate the management strategies in order to reduce the morb idity and mortality in the patients of HIV induced renal dysfunction.
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